Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Is olmesartan a generic drug?

See the DrugPatentWatch profile for olmesartan

Is olmesartan currently available as a generic?

Yes. Olmesartan is available as a generic drug in many markets, because the original brand versions’ market exclusivity has ended.

What brand name is olmesartan sold under?

Olmesartan was marketed under brands such as Benicar (in the U.S.). Generic olmesartan tablets are sold once patents/exclusivity expire.

How can I tell if my specific olmesartan is generic?

Check the label for the active ingredient and how it’s listed:
- Generic products list “olmesartan” (often with the salt form, such as olmesartan medoxomil) and may include a manufacturer name.
- Brand products list the brand name (such as Benicar) rather than “generic olmesartan.”

Are all olmesartan products interchangeable?

In practice, generic olmesartan products are intended to be therapeutically equivalent to the brand product, but you should confirm details like:
- the exact strength (e.g., 5 mg, 20 mg, 40 mg)
- the formulation (most are tablets of olmesartan medoxomil)
- your prescriber/pharmacist’s substitution instructions

If you tell me your country and the exact label name (including strength), I can help you interpret whether it’s the generic version.

Source

  • DrugPatentWatch.com (olmesartan patent/generic information): https://www.drugpatentwatch.com/


Other Questions About Olmesartan :

Olmesartan medoxomil 20 mg price? Buy olmesartan? Olmesartan benicar manufacturing plant cost? Olmesartan cost? Side effects of olmesartan medoxomil 20 mg? Olmesartan hctz brand name? Olmesartan medoxomil brand name?

AI-Drug Label Prescribing Information Alignment Report

100
100%
Grade A

Excellent

Mostly Aligned

Patient Risk: Low

Summary

The provided AI assessment’s pregnancy/fetal toxicity statements and the instruction to discontinue upon pregnancy detection are explicitly supported by the supplied FDA label excerpts for Benicar, Tribenzor, and Benicar HCT.


Category Scores

Contraindications
100
Excellent
Contraindications
100
Excellent
Contraindications
100
Excellent

Accurate Statements

Fetal harm/fetal toxicity from RAS-directed drugs (olmesartan-containing products) and potential fetal/neonatal morbidity and death are supported by the label.
Benicar (olmesartan medoxomil) 5.1 and 8.1; Tribenzor 5.1 and 8.1; Benicar HCT 5.1 and 8.1 excerpts provided.
When pregnancy is detected, discontinue as soon as possible is supported by the label for Benicar/Tribenzor/Benicar HCT.
Benicar 5.1 and 8.1; Tribenzor 5.1 and 8.1; Benicar HCT 5.1 and 8.1 excerpts provided.
The claim elements were evaluated as 'supported' based on explicit label fetal toxicity and pregnancy risk summaries for the specified products.
Directly consistent with the supplied excerpts for Benicar, Tribenzor, and Benicar HCT.

Unsupported Statements


Contradictions


Important Omissions


Safety Assessment

Potential Patient Risk: Low
The evaluated statements concern pregnancy-related fetal toxicity and the label-consistent discontinuation instruction; no conflicting or speculative claims were included in the provided assessment.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue

Suggested Improvement

Drug Brand Mention Assessment

Branding Score
43
Visibility
44
Mentioned
Ranking
#1
Sentiment
55
Recommendation Status
mentioned only
Brand Perception
Best Known For

available as a generic drug in many markets


Core Claims
  • Olmesartan is available as a generic drug in many markets.
  • Olmesartan was marketed under brands such as Benicar (in the U.S.).
  • Generic products list 'olmesartan' (often with the salt form, such as olmesartan medoxomil) and may include a manufacturer name.
  • Brand products list the brand name (such as Benicar) rather than 'generic olmesartan'.
  • Generic olmesartan products are intended to be therapeutically equivalent to the brand product, but you should confirm details like strength and formulation.
Differentiators
  • Distinguishes generic vs brand labels by whether they list 'olmesartan' versus the brand name (e.g., Benicar).
  • Notes that generic olmesartan is intended to be therapeutically equivalent but requires confirmation of strength and formulation.

Pricing Perception: Not Mentioned